California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 8, 2026

7 hours ago

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

7 hours ago

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

7 hours ago

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Indeterminate GlobeNewswire

7 hours ago

R1 Makes Fast Company’s Eighth Annual List of the Best Workplaces for Innovators in Biotech, Healthcare and Life Sciences

Indeterminate GlobeNewswire

7 hours ago

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire

7 hours ago

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings

Indeterminate GlobeNewswire

7 hours ago

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire

7 hours ago

Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

7 hours ago

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire

7 hours ago

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

7 hours ago

BioVie Announces Update to Parkinson’s Phase 3 Development Program

Indeterminate GlobeNewswire

7 hours ago

BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

Indeterminate GlobeNewswire

7 hours ago

BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™

Indeterminate GlobeNewswire

7 hours ago

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire

7 hours ago

Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026

Indeterminate GlobeNewswire

7 hours ago

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Indeterminate GlobeNewswire

8 hours ago

Generate Biomedicines Inc. to Participate in September Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

8 hours ago

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire